- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Capital Research Global Investors Reduces Stake in Johnson & Johnson
Institutional investor sells over 372,000 shares of pharmaceutical giant
Mar. 11, 2026 at 8:36am
Got story updates? Submit your updates here. ›
Capital Research Global Investors, a major institutional investor, has reduced its stake in Johnson & Johnson (NYSE: JNJ) by 11%, selling 372,720 shares in the third quarter. The fund now owns 3,014,727 shares of the company's stock, worth approximately $559 million as of the most recent SEC filing.
Why it matters
This reduction in ownership by a prominent institutional investor could signal a shift in sentiment around Johnson & Johnson's stock. Institutional investors like Capital Research Global Investors play a significant role in driving stock prices, so their trading activity is closely watched by the market.
The details
According to the SEC filing, Capital Research Global Investors sold the 372,720 shares of Johnson & Johnson during the third quarter. This represents an 11% reduction in the fund's total position in the company. The fund now owns approximately 0.13% of Johnson & Johnson's outstanding shares.
- Capital Research Global Investors reduced its stake in Johnson & Johnson in the third quarter of 2026.
The players
Capital Research Global Investors
A major institutional investor and asset management firm.
Johnson & Johnson
A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.
The takeaway
This reduction in ownership by a prominent institutional investor like Capital Research Global Investors could signal a potential shift in sentiment around Johnson & Johnson's stock. Investors will likely be closely monitoring the company's performance and any further changes in institutional ownership in the coming quarters.
